Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Growth Analysis: How Will Revenue Expand During The Forecast Period?

The market for ophthalmic artificial intelligence-assisted diagnosis has experienced significant expansion in recent years. From $2.17 billion in 2025, it is projected to reach $2.57 billion in 2026, reflecting a compound annual growth rate (CAGR) of 18.5%. The historic period’s growth has been driven by factors such as the growing use of digital imaging devices, a higher incidence of eye conditions, greater emphasis on early detection, the incorporation of AI into clinical studies, and progress in retinal imaging technology.

The size of the market for ophthalmic artificial intelligence-assisted diagnosis is projected to experience swift expansion over the coming years. By 2030, it is forecasted to reach $5.03 billion, driven by a compound annual growth rate (CAGR) of 18.2%. This anticipated growth during the forecast period is fueled by the rise of cloud-based AI diagnostic platforms, the broadening of tele-ophthalmology services, the enhancement of AI algorithms specifically designed for rare eye disorders, strategic partnerships forged between AI developers and hospitals, and an increasing uptake of predictive ophthalmology. Key trends shaping this period include the use of AI for retinal imaging analysis, disease detection powered by deep learning, the development of predictive ophthalmology models, the automation of patient record analysis, and the seamless incorporation of AI into clinical workflows.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28285&type=smp

Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Opportunity Drivers: What Is Creating New Revenue Potential?

The increasing frequency of eye diseases is anticipated to fuel the expansion of the ophthalmic artificial intelligence-assisted diagnosis market in the coming years. Eye diseases encompass medical conditions or anomalies that impair the structure or functionality of the eye, potentially compromising vision or ocular health. Their rise is attributed to extended screen time from use of digital devices, resulting in digital eye strain, dryness, and lasting vision problems due to prolonged blue light exposure and decreased blink rates. Ophthalmic artificial intelligence-assisted diagnosis aids by examining medical imagery and patient information to identify, categorize, and forecast eye diseases early and with precision, facilitating prompt intervention and lowering the likelihood of vision loss. For example, in August 2023, the World Health Organization (WHO), a United Nations agency based in Switzerland, reported that estimates from 2023 indicate over 2.2 billion people globally have near or distance vision impairment—more than 1 billion of these cases are preventable or untreated—while refractive errors and cataracts remain the primary causes, and access to effective treatment reaches just 36% of those with refractive error-related impairment and only 17% of individuals with cataract-related impairment. As a result, the growing prevalence of eye disorders is propelling the ophthalmic artificial intelligence-assisted diagnosis market forward.

Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Segmentation And Category Breakdown

The ophthalmic artificial intelligence-assisted diagnosis market covered in this report is segmented –

1) By Type: Cloud-Based, On-Premises

2) By Technology: Deep Learning, Machine Learning, Computer Vision, Other Technologies

3) By Application: Hospital, Clinic, Imaging Centre

Subsegments:

1) By Cloud-Based: Public Cloud, Private Cloud, Hybrid Cloud

2) By On-Premises: Local Server Deployment, Enterprise Data Center Deployment, Private Network Deployment

Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Innovation Trends Driving Future Development

Leading players within the ophthalmic AI-driven diagnostic sector are concentrating on the creation of cutting-edge tools, such as an ocular data-as-a-service platform, aimed at boosting diagnostic precision, simplifying patient management, and offering forward-looking insights for eye conditions. An ocular data-as-a-service platform is a digital system that supplies eye health information on request, allowing eye care professionals, medical facilities, and AI diagnostic applications to remotely retrieve, exchange, and evaluate retinal images and other ocular data for enhanced diagnosis, observation, and research activities. For example, in May 2025, Topcon Healthcare Solutions Inc., a U.S.-headquartered firm specializing in digital healthcare technologies, introduced IDHea, a solution intended to streamline ophthalmic evaluations and elevate patient results. This cloud-based system expedites AI and digital health progress by offering rapid and secure access to authentic and clinical ocular data sets. It enables investigators to achieve notable advances in managing both eye and systemic illnesses by turning clinical data into useful, AI-generated insights. Based on the FAST framework—Fast, Accessible, Safe, and Transparent—IDHea facilitates predictive, customized, and preemptive patient care while maintaining stringent privacy and governance protocols.

Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Competitive Analysis Of Major Industry Participants

Major companies operating in the ophthalmic artificial intelligence-assisted diagnosis market are IDx Technologies Inc., Digital Diagnostics Inc., AEYE Health Inc., Eyenuk Inc., OphtAI, Oivi Tech Private Limited, Altris Inc., JuneBrain Inc., Mediwhale Inc., MONA.health BV, Remidio Innovative Solutions Pvt. Ltd., Retinalyze System A/S, Retmarker, RetinaRisk, Ikerian AG, VoxelCloud Inc., Visulytix Ltd., Aiforia Technologies Plc, DeepTek Inc., EyRIS Pte Ltd., Neurodynamics Solutions Inc.

Access The Complete Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Report:

https://www.thebusinessresearchcompany.com/report/ophthalmic-artificial-intelligence-assisted-diagnosis-global-market-report

Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Regional Analysis And Leading Geography

North America was the largest region in the ophthalmic artificial intelligence-assisted diagnosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ophthalmic artificial intelligence-assisted diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=28285&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model